JP2016516415A5 - - Google Patents

Download PDF

Info

Publication number
JP2016516415A5
JP2016516415A5 JP2016504431A JP2016504431A JP2016516415A5 JP 2016516415 A5 JP2016516415 A5 JP 2016516415A5 JP 2016504431 A JP2016504431 A JP 2016504431A JP 2016504431 A JP2016504431 A JP 2016504431A JP 2016516415 A5 JP2016516415 A5 JP 2016516415A5
Authority
JP
Japan
Prior art keywords
plant
nucleic acid
modified
protein
vlp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016504431A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016516415A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2014/050326 external-priority patent/WO2014153674A1/en
Publication of JP2016516415A publication Critical patent/JP2016516415A/ja
Publication of JP2016516415A5 publication Critical patent/JP2016516415A5/ja
Pending legal-status Critical Current

Links

JP2016504431A 2013-03-28 2014-03-28 植物におけるインフルエンザウイルス様粒子の生成 Pending JP2016516415A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201361806227P 2013-03-28 2013-03-28
US61/806,227 2013-03-28
US201461925852P 2014-01-10 2014-01-10
US61/925,852 2014-01-10
US201461971274P 2014-03-27 2014-03-27
US61/971,274 2014-03-27
PCT/CA2014/050326 WO2014153674A1 (en) 2013-03-28 2014-03-28 Influenza virus-like particle production in plants

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019067570A Division JP7065803B2 (ja) 2013-03-28 2019-03-29 植物におけるインフルエンザウイルス様粒子の生成

Publications (2)

Publication Number Publication Date
JP2016516415A JP2016516415A (ja) 2016-06-09
JP2016516415A5 true JP2016516415A5 (https=) 2017-03-09

Family

ID=51622327

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016504431A Pending JP2016516415A (ja) 2013-03-28 2014-03-28 植物におけるインフルエンザウイルス様粒子の生成
JP2019067570A Active JP7065803B2 (ja) 2013-03-28 2019-03-29 植物におけるインフルエンザウイルス様粒子の生成

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019067570A Active JP7065803B2 (ja) 2013-03-28 2019-03-29 植物におけるインフルエンザウイルス様粒子の生成

Country Status (14)

Country Link
US (2) US10358652B2 (https=)
EP (2) EP2978848B1 (https=)
JP (2) JP2016516415A (https=)
KR (1) KR102199018B1 (https=)
CN (2) CN105247059B (https=)
AU (1) AU2014245779B2 (https=)
ES (1) ES2803508T3 (https=)
IL (2) IL241692B2 (https=)
MX (1) MX376138B (https=)
PH (1) PH12015502217B1 (https=)
RU (2) RU2742607C1 (https=)
SG (1) SG11201507928QA (https=)
WO (1) WO2014153674A1 (https=)
ZA (1) ZA201508327B (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ622731A (en) 2011-09-30 2016-04-29 Medicago Inc Increasing virus-like particle yield in plants
US11390878B2 (en) 2011-09-30 2022-07-19 Medicago Inc. Increasing protein yield in plants
ES2803508T3 (es) * 2013-03-28 2021-01-27 Medicago Inc Producción de partículas similares al virus de la gripe en plantas
US12467058B2 (en) 2013-03-28 2025-11-11 Aramis Biotechnologies Inc. Influenza virus-like particle production in plants
RU2699982C2 (ru) * 2014-01-10 2019-09-11 Медикаго Инк. Энхансерные элементы cpmv
US10563213B2 (en) 2014-03-27 2020-02-18 Medicago Inc. Modified CPMV enhancer elements
PL4023249T3 (pl) 2014-04-23 2025-03-10 Modernatx, Inc. Szczepionki z kwasem nukleinowym
FR3054547B1 (fr) 2016-07-29 2020-06-05 Angany Inc. Particules pseudo-virales et leurs utilisations
GB201614485D0 (en) 2016-08-25 2016-10-12 Univ Oxford Innovation Ltd Immunogenic composition
CN106822887A (zh) * 2017-01-26 2017-06-13 中国科学院微生物研究所 一种流感病毒四价亚单位疫苗及其应用
CN112400021A (zh) * 2018-03-14 2021-02-23 麦迪卡格公司 植物表达增强子
EP3814509A4 (en) * 2018-06-27 2022-07-27 Medicago Inc. INFLUENCE VIRUS HEMAGGLUTININ MUTANTS
WO2020181354A1 (en) * 2019-03-14 2020-09-17 Mitsubishi Tanabe Pharma Corporation Endogenous plant expression enhancer
CN113249399B (zh) * 2021-05-27 2022-08-02 长沙诺合松生物科技合伙企业(有限合伙) pAM基因及其植物表达载体和应用
US20250325649A1 (en) * 2021-12-31 2025-10-23 Mynvax Private Limited Polypeptide fragments, immunogenic composition against influenza virus, and implementations thereof
WO2025102071A1 (en) * 2023-11-09 2025-05-15 The General Hospital Corporation Hemagglutinin polypeptides and uses thereof
WO2026027730A1 (en) * 2024-07-31 2026-02-05 Sanofi Modified h5 influenza hemagglutinin polypeptides and nucleic acids and uses thereof

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232833A (en) 1988-09-14 1993-08-03 Stressgen Biotechnologies Corporation Accumulation of heat shock proteins for evaluating biological damage due to chronic exposure of an organism to sublethal levels of pollutants
US6392121B1 (en) 1998-10-07 2002-05-21 Boyce Thompson Institute For Plant Research Gemini virus vectors for gene expression in plants
US20020169306A1 (en) * 1999-05-18 2002-11-14 Kaio Kitazato Envelope gene-deficient paramyxovirus vector
MXPA02005559A (es) 1999-12-06 2004-09-10 Univ Illinois Proteinas de tcr de alta afinidad y metodos.
DE10109354A1 (de) 2001-02-27 2002-09-05 Icon Genetics Ag Rekombinante virale Schaltersysteme
US20030180756A1 (en) * 2002-03-21 2003-09-25 Yang Shi Compositions and methods for suppressing eukaryotic gene expression
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
KR20060035596A (ko) 2003-05-05 2006-04-26 보이스 톰슨 인스터튜트 포 플랜트 리서치 외래유전자도입 식물로부터 유래된 면역보호성 조성물을제조하기 위한 벡터와 세포
BRPI0410342A (pt) * 2003-05-05 2006-06-20 Dow Agrosciences Llc composições imunoprofiláticas e terapêuticas estáveis derivadas de células vegetais transgênicas e processos para produção
US8080255B2 (en) 2003-07-11 2011-12-20 Novavax Inc. Functional influenza virus like particles (VLPs)
US8420102B2 (en) * 2006-03-07 2013-04-16 Vaxinnate Corporation Compositions that include hemagglutinin
ES2662118T3 (es) 2005-04-29 2018-04-05 University Of Cape Town Expresión de proteínas virales en las plantas
KR101359723B1 (ko) 2005-10-18 2014-02-05 노바백스, 인코포레이티드 기능성 인플루엔자 바이러스 유사 입자들
KR20090034297A (ko) 2006-02-16 2009-04-07 더 거번먼트 오브 더 유나이티드 스테이츠 오브 어메리카 애즈 레프리젠티드 바이 더 세크러터리 오브 더 디파트먼트 오브 헬쓰 앤드 휴먼 써비시즈 인플루엔자에 대한 항바이러스제 및 백신
US7618815B2 (en) 2006-03-08 2009-11-17 University Of Kentucky Research Foundation Viral vectors useful in soybean and methods of use
CA2651907C (en) 2006-05-22 2016-12-20 Plant Bioscience Limited Bipartite system, method and composition for the constitutive and inducible expression of high levels of foreign proteins in plants
CN104140958A (zh) 2006-08-09 2014-11-12 米迪缪尼有限公司 流感血凝素和神经氨酸酶变体
WO2008148104A1 (en) 2007-05-25 2008-12-04 Novavax, Inc. Novel vlps derived from cells that do not express a viral matrix or core protein
DK2155880T3 (en) 2007-06-15 2016-12-05 Medicago Inc Modification of glycoproteinproduktion i plants
CA2615372A1 (en) * 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
WO2009076778A1 (en) * 2007-11-27 2009-06-25 Medicago Inc. Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
GB0800272D0 (en) 2008-01-08 2008-02-13 Plant Bioscience Ltd Protein expression systems
SG187500A1 (en) * 2008-01-21 2013-02-28 Medicago Inc Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
AU2009267769B2 (en) 2008-07-08 2015-07-16 Medicago Inc. Soluble recombinant influenza antigens
NZ590351A (en) 2008-07-18 2012-11-30 Medicago Inc HA1 domain totally or partially free of N-linked glycosylation operatively linked to a regulatory region
CA2736796A1 (en) 2008-08-27 2010-03-04 Arizona Board Of Regents For And On Behalf Of Arizona State University A dna replicon system for high-level rapid production of vaccines and monoclonal antibody therapeutics in plants
WO2010117786A1 (en) * 2009-03-30 2010-10-14 Mount Sinai School Of Medicine Of New York University Influenza virus vaccines and uses thereof
HUE039100T2 (hu) * 2009-06-24 2018-12-28 Medicago Inc Hemagglutinint tartalmazó kimer influenzavírus-jellegû részecskék
FR2947875B1 (fr) 2009-07-10 2011-07-08 Raymond A & Cie Dispositif de fixation a elements de fixation multiples dont l'un est flottant
WO2011011390A1 (en) 2009-07-20 2011-01-27 Novavax, Inc. Purified recombinant influenza virus ha proteins
CN102753700A (zh) 2009-09-04 2012-10-24 先正达参股股份有限公司 增加植物中多肽表达的翻译增强子元件堆叠
KR101773431B1 (ko) 2009-09-22 2017-09-12 메디카고 인코포레이티드 식물-유래 vlp의 제조방법
JP2013520167A (ja) 2010-02-18 2013-06-06 テクノヴァックス,インコーポレイテッド 万能ウイルス様粒子(vlp)インフルエンザワクチン
JP6029586B2 (ja) * 2010-10-04 2016-11-24 マサチューセッツ インスティテュート オブ テクノロジー 血球凝集素ポリペプチド、ならびにそれに関連する試薬および方法
WO2012058762A1 (en) 2010-11-04 2012-05-10 Medicago Inc. Plant expression system
TWI526539B (zh) 2010-12-22 2016-03-21 苜蓿股份有限公司 植物中生產類病毒顆粒(vlp)的方法及以該方法生產之vlp
TWI620816B (zh) 2011-03-23 2018-04-11 苜蓿股份有限公司 植物衍生蛋白回收方法
KR101963792B1 (ko) 2011-06-13 2019-07-31 메디카고 인코포레이티드 식물에서 광견병 바이러스 유사 입자 생성
PL220281B1 (pl) 2011-09-23 2015-09-30 Inst Biochemii I Biofizyki Polskiej Akademii Nauk Szczepionka DNA, sposób indukowania odpowiedzi immunologicznej, przeciwciała specyficznie rozpoznające białko hemaglutyniny H5 wirusa grypy i zastosowanie szczepionki DNA
US11390878B2 (en) * 2011-09-30 2022-07-19 Medicago Inc. Increasing protein yield in plants
NZ622731A (en) 2011-09-30 2016-04-29 Medicago Inc Increasing virus-like particle yield in plants
BR112014011345A2 (pt) 2011-11-11 2017-05-16 Philip Morris Products Sa partículas tipo vírus da influenza (vlps) compreendendo nicotiana tabacum produzida por hemaglutinina
US9555094B2 (en) 2012-07-23 2017-01-31 The Institute Of Biological Resources Isolated nucleic acid for the production of a vaccine against virus
ES2803508T3 (es) 2013-03-28 2021-01-27 Medicago Inc Producción de partículas similares al virus de la gripe en plantas

Similar Documents

Publication Publication Date Title
JP2016516415A5 (https=)
RU2015146097A (ru) Получение вирусоподобных частиц вируса гриппа в растениях
JP2019141061A5 (https=)
AU2021201844B2 (en) High titer recombinant influenza viruses with enhanced replication in mdck or vero cells or eggs
US12365880B2 (en) Recombinant influenza viruses with stabilized NA
JP7575012B2 (ja) 卵における複製のための安定化されたhaを有する組換えインフルエンザウイルス
JP6324725B2 (ja) 発現系
US11389523B2 (en) Vectors for eliciting immune responses to non-dominant epitopes in the hemagglutinin (HA) protein
JP2016052331A5 (https=)
US11807872B2 (en) Recombinant influenza viruses with stabilized HA for replication in eggs
CA2730668C (en) New influenza virus immunizing epitope
CA2730185C (en) Influenza virus-like particles (vlps) comprising hemagglutinin
US10633422B2 (en) Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA
JP2010533001A5 (https=)
JP2014097076A (ja) ヘマグルチニンを発現するトランスジェニック植物において産生された組換え型インフルエンザウイルス様粒子(vlp)
RU2014116371A (ru) Повышение выхода вирусоподобных частиц в растениях
JP2015506705A5 (https=)
US11058766B2 (en) Universal vaccine platform
CA2986701A1 (en) Methods of optimizing nucleotide sequences encoding engineered influenza proteins
JP2019500320A5 (https=)
JP2024537250A (ja) インフルエンザワクチン
WO2011007339A3 (en) Chimeric foot and mouth disease viruses
Deng et al. Developments of subunit and VLP vaccines against influenza A virus
JP2019506168A5 (https=)
Sączyńska Influenza virus hemagglutinin as a vaccine antigen produced in bacteria.